Avita Medical share price on watch after being added to the ASX 200

The Avita Medical Ltd (ASX:AVH) share price could be on the rise today after the medical technology company was added to the ASX 200 index…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Avita Medical Ltd (ASX: AVH) share price could push higher on Friday after it became the latest addition to the ASX 200 index.

Why is Avita Medical joining the ASX 200?

After the market close on Thursday, S&P Dow Jones Indices announced that it will remove Aveo Group (ASX: AOG) from the S&P/ASX 200 on November 14.

This is because earlier in the week the retirement communities company's shareholders voted in favour of the scheme of arrangement that will see Brookfield Asset Management Inc acquire 100% of Aveo.

Brookfield Asset Management will pay a total consideration of $2.195 per share to Aveo shareholders. This is inclusive of the FY 2019 final distribution of 4.5 cents per security.

Whilst there were a good number of candidates to replace Aveo in the benchmark index, S&P Dow Jones Indices elected to choose Avita Medical.

This caps off a remarkable year for Avita Medical and its shareholders. On January 1 the medical technology company's shares were largely under the radar of most investors and changing hands at just 8 cents. Now they are trading 719% higher at 65.5 cents, giving it a market capitalisation of ~$1.2 billion.

What is Avita Medical?

Avita Medical is a regenerative medicine company with a technology platform positioned to address unmet medical needs in therapeutic skin restoration.

The company's FDA-approved RECELL System is indicated for use in the treatment of acute thermal burns in patients 18 years and older. It is used to prepare Spray-On Skin Cells using a small amount of a patient's own skin. This provides a new way to treat severe burns, while significantly reducing the amount of donor skin required.

A series of clinical trials in major U.S. burn centres have shown that the system is a significant advancement over the current standard of care for burn patients and offers benefits in clinical outcomes and cost savings.

Unsurprisingly, this has led to the company recording very strong sales growth in FY 2020. Last month it reported first quarter sales of A$7.9 million, up 165% on the prior corresponding period.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A man cheers after winning computer game while woman sitting next to him looks upset.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the trading week today.

Read more »

Three business people stand on platforms in the desert and look out through telescopes.
Best Shares

1 ASX dividend share set to excel long term, even while down 13%

Good quality shares don't often sell off at this margin.

Read more »

Two people comparing and analysing material.
Broker Notes

Buy, hold, sell: Netwealth, Santos, and South32 shares

Morgans has given its verdict on these shares following updates.

Read more »

Emotional euphoric young woman giving high five to male partner, celebrating family achievement, getting bank loan approval, or financial or investing success.
Share Gainers

Why Life360, Northern Star, Objective Corp, and Rox shares are charging higher today

These shares are having a strong finish to the week. But why?

Read more »

A woman sits on sofa pondering a question.
Share Market News

Insignia Financial responds to ASX on disclosure and governance

Insignia Financial updates shareholders on ASX compliance and new governance controls around performance rights disclosure.

Read more »

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
Share Fallers

Why Capstone Copper, Dateline, DroneShield, and Lindian shares are falling today

These shares are ending the week in the red. But why?

Read more »

Business man at desk looking out window with his arms behind his head at a view of the city and stock trends overlay.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

2 people using their iPhones
Share Market News

Life360 posts record Q4 as revenue and EBITDA top guidance

Life360 reported record Q4 user and subscriber growth, with full-year revenue and EBITDA set to exceed guidance.

Read more »